Related references
Note: Only part of the references are listed.Current status of conversion surgery for stage IV gastric cancer
Jun Kinoshita et al.
SURGERY TODAY (2021)
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer
Kei Yamamoto et al.
CANCER SCIENCE (2020)
The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study
Naohiko Nakamura et al.
BMC CANCER (2020)
Targeting of CD163+Macrophages in Inflammatory and Malignant Diseases
Maria K. Skytthe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The emerging roles of macrophages in cancer metastasis and response to chemotherapy
Luis Rivera Sanchez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment
Amy J. Petty et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The clinical role of the TME in solid cancer
Nicolas A. Giraldo et al.
BRITISH JOURNAL OF CANCER (2019)
Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer
Shi-Chao Zhang et al.
JOURNAL OF CANCER (2019)
Surgical management of metastatic gastric cancer: moving beyond the guidelines
Ali Guner et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy
Nikolai Litviakov et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
Hironori Ishigami et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic significance of the infiltration of CD163(+) macrophages combined with CD66b(+) neutrophils in gastric cancer
Xiaopei Huang et al.
CANCER MEDICINE (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?
Yasuhiro Kodera
ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer
Yeonjoo Choi et al.
GASTRIC CANCER (2017)
Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study
Yasushi Sato et al.
GASTRIC CANCER (2017)
Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification
Kazuhiro Yoshida et al.
GASTRIC CANCER (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer
J. Kinoshita et al.
EJSO (2015)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Nesrine I. Affara et al.
CANCER CELL (2014)
Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A)
Yukinori Kurokawa et al.
GASTRIC CANCER (2014)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
Systematic validation of specific phenotypic markers for in vitro polarized human macrophages
C. A. Ambarus et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
Sofia Edin et al.
PLOS ONE (2012)
The Ratio of Intra-Tumoral Regulatory T Cells (Foxp3+)/Helper T Cells (CD4+) Is a Prognostic Factor and Associated With Recurrence Pattern in Gastric Cardia Cancer
Hyoung-Il Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases
Sachio Fushida et al.
ANTI-CANCER DRUGS (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Share Paper
